{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:22:01Z","timestamp":1793744521331,"version":"4.6.1"},"reference-count":43,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.1001\/jamaneurol.2021.3310","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T15:45:40Z","timestamp":1632757540000},"page":"1345","source":"Crossref","is-referenced-by-count":295,"title":["Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity"],"prefix":"10.1001","volume":"78","author":[{"given":"Keith","family":"Vossel","sequence":"first","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"},{"name":"N. Bud Grossman Center for Memory Research and Care, Department of Neurology, University of Minnesota, Minneapolis"},{"name":"Institute for Translational Neuroscience, University of Minnesota, Minneapolis"},{"name":"Mary S. Easton Center for Alzheimer\u2019s Disease Research, Department of Neurology, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles"},{"name":"Gladstone Institute of Neurological Disease, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalini G.","family":"Ranasinghe","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Beagle","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"La","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasey","family":"Ah Pook","sequence":"additional","affiliation":[{"name":"N. Bud Grossman Center for Memory Research and Care, Department of Neurology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn","family":"Castro","sequence":"additional","affiliation":[{"name":"N. Bud Grossman Center for Memory Research and Care, Department of Neurology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Mizuiri","sequence":"additional","affiliation":[{"name":"Biomagnetic Imaging Laboratory, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne M.","family":"Honma","sequence":"additional","affiliation":[{"name":"Biomagnetic Imaging Laboratory, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Venkateswaran","sequence":"additional","affiliation":[{"name":"N. Bud Grossman Center for Memory Research and Care, Department of Neurology, University of Minnesota, Minneapolis"},{"name":"Mary S. Easton Center for Alzheimer\u2019s Disease Research, Department of Neurology, David Geffen School of Medicine at UCLA (University of California, Los Angeles), Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Koestler","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Zhang","sequence":"additional","affiliation":[{"name":"Minnesota Epilepsy Group, St Paul, Minnesota"},{"name":"Department of Neurology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Mucke","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"},{"name":"Gladstone Institute of Neurological Disease, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Howell","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Possin","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel H.","family":"Kramer","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikantan S.","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Biomagnetic Imaging Laboratory, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi E.","family":"Kirsch","sequence":"additional","affiliation":[{"name":"Biomagnetic Imaging Laboratory, Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco"},{"name":"Epilepsy Center, Department of Neurology, University of California, San Francisco, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"noi210060r1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1474-4422(18)30403-4","article-title":"Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"GBD 2016 Dementia Collaborators","year":"2019","journal-title":"Lancet Neurol"},{"issue":"9","key":"noi210060r2","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1001\/jamaneurol.2013.136","article-title":"Seizures and epileptiform activity in the early stages of Alzheimer disease.","volume":"70","author":"Vossel","year":"2013","journal-title":"JAMA Neurol"},{"issue":"11","key":"noi210060r3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.2165\/00002512-200320110-00001","article-title":"Seizures in elderly patients with dementia: epidemiology and management.","volume":"20","author":"Mendez","year":"2003","journal-title":"Drugs Aging"},{"issue":"4","key":"noi210060r4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1474-4422(17)30044-3","article-title":"Epileptic activity in Alzheimer\u2019s disease: causes and clinical relevance.","volume":"16","author":"Vossel","year":"2017","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi210060r5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/epi.2006.47.issue-5","article-title":"Incidence and predictors of seizures in patients with Alzheimer\u2019s disease.","volume":"47","author":"Amatniek","year":"2006","journal-title":"Epilepsia"},{"issue":"6","key":"noi210060r6","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.v80.6","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer\u2019s disease.","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann Neurol"},{"issue":"3","key":"noi210060r7","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3233\/JAD-170925","article-title":"Prevalence, semiology, and risk factors of epilepsy in Alzheimer\u2019s disease: an ambulatory EEG study.","volume":"63","author":"Horvath","year":"2018","journal-title":"J Alzheimers Dis"},{"issue":"16","key":"noi210060r8","doi-asserted-by":"publisher","first-page":"e2259","DOI":"10.1212\/WNL.0000000000010612","article-title":"Association of epileptiform abnormalities and seizures in Alzheimer disease.","volume":"95","author":"Lam","year":"2020","journal-title":"Neurology"},{"issue":"8","key":"noi210060r9","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","article-title":"Subclinical epileptiform activity accelerates the progression of Alzheimer\u2019s disease: a long-term EEG study.","volume":"132","author":"Horvath","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"noi210060r10","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3389\/fneur.2019.01266","article-title":"A longitudinal study of epileptic seizures in Alzheimer\u2019s disease.","volume":"10","author":"Baker","year":"2019","journal-title":"Front Neurol"},{"issue":"10","key":"noi210060r11","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1007\/s00415-020-09937-7","article-title":"Seizures in Alzheimer\u2019s disease are highly recurrent and associated with a poor disease course.","volume":"267","author":"Voglein","year":"2020","journal-title":"J Neurol"},{"issue":"42","key":"noi210060r12","doi-asserted-by":"publisher","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer\u2019s disease model.","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"noi210060r13","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.celrep.2017.06.040","article-title":"?FosB regulates gene expression and cognitive dysfunction in a mouse model of Alzheimer\u2019s disease.","volume":"20","author":"Corbett","year":"2017","journal-title":"Cell Rep"},{"issue":"11","key":"noi210060r14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/cns.2013.19.issue-11","article-title":"Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe\/PS1dE9 transgenic mice.","volume":"19","author":"Shi","year":"2013","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"noi210060r15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-015-0110-9","article-title":"Brivaracetam, but not ethosuximide, reverses memory impairments in an Alzheimer\u2019s disease mouse model.","volume":"7","author":"Nygaard","year":"2015","journal-title":"Alzheimers Res Ther"},{"key":"noi210060r16","author":"Fu","year":"2019"},{"issue":"4","key":"noi210060r17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.yebeh.2010.01.015","article-title":"Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer\u2019s disease.","volume":"17","author":"Cumbo","year":"2010","journal-title":"Epilepsy Behav"},{"issue":"6","key":"noi210060r18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm.4330","article-title":"Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer\u2019s disease.","volume":"23","author":"Lam","year":"2017","journal-title":"Nat Med"},{"issue":"20","key":"noi210060r19","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"3","key":"noi210060r20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease.","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"3","key":"noi210060r21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-Mental State\u201d: a practical method for grading the cognitive state of patients for the clinician.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"11","key":"noi210060r22","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules.","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"noi210060r23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1017\/S1355617713001094","article-title":"NIH EXAMINER: conceptualization and development of an executive function battery.","volume":"20","author":"Kramer","year":"2014","journal-title":"J Int Neuropsychol Soc"},{"issue":"11","key":"noi210060r24","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease.","volume":"141","author":"Rosen","year":"1984","journal-title":"Am J Psychiatry"},{"key":"noi210060r26","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1192\/bjp.177.3.252","article-title":"The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale: two methods to assess fluctuating confusion in dementia.","volume":"177","author":"Walker","year":"2000","journal-title":"Br J Psychiatry"},{"key":"noi210060r27","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer\u2019s disease: the Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"noi210060r28","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer\u2019s Disease Cooperative Study\u2013Clinical Global Impression of Change. the Alzheimer\u2019s Disease Cooperative Study.","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"12","key":"noi210060r29","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia.","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"5","key":"noi210060r31","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000278620","article-title":"Prevalence and clinical significance of epileptiform EEG discharges in a large memory clinic cohort.","volume":"29","author":"Liedorp","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"24","key":"noi210060r32","doi-asserted-by":"publisher","first-page":"e3248","DOI":"10.1212\/WNL.0000000000011080","article-title":"Dementia in late-onset epilepsy: the Atherosclerosis Risk in Communities study.","volume":"95","author":"Johnson","year":"2020","journal-title":"Neurology"},{"key":"noi210060r33","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50333","article-title":"Mechanisms of hyperexcitability in Alzheimer\u2019s disease hiPSC-derived neurons and cerebral organoids vs isogenic controls.","volume":"8","author":"Ghatak","year":"2019","journal-title":"Elife"},{"key":"noi210060r34","author":"Zott","year":"2019"},{"key":"noi210060r39","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.nicl.2015.02.009","article-title":"Response of the medial temporal lobe network in amnestic mild cognitive impairment to therapeutic intervention assessed by fMRI and memory task performance.","volume":"7","author":"Bakker","year":"2015","journal-title":"Neuroimage Clin"},{"issue":"1","key":"noi210060r40","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer\u2019s disease, dementia with Lewy bodies, and frontotemporal dementia.","volume":"60","author":"Beagle","year":"2017","journal-title":"J Alzheimers Dis"},{"issue":"534","key":"noi210060r41","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4069","article-title":"Neurophysiological signatures in Alzheimer\u2019s disease are distinctly associated with TAU, amyloid-\u00df accumulation, and cognitive decline.","volume":"12","author":"Ranasinghe","year":"2020","journal-title":"Sci Transl Med"},{"issue":"4","key":"noi210060r42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3233\/JAD-160742","article-title":"Levetiracetam alters oscillatory connectivity in Alzheimer\u2019s disease.","volume":"58","author":"Musaeus","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"noi210060r43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.3389\/fneur.2019.00959","article-title":"New approaches to studying silent mesial temporal lobe seizures in Alzheimer\u2019s disease.","volume":"10","author":"Lam","year":"2019","journal-title":"Front Neurol"},{"key":"noi210060r30","author":"Cohen"},{"key":"noi210060r25","unstructured":"Memory and Aging Center, Weill Institute for Neurosciences, University of California, San Francisco. EXAMINER. Regents of the University of California; 2021. Accessed April 25, 2021. https:\/\/memory.ucsf.edu\/research-trials\/professional\/examiner"},{"key":"noi210060r35","unstructured":"An Investigation of levetiracetam in Alzheimer's disease (ILiAD). ClinicalTrials.gov identifier: NCT03489044. Updated April 28, 2021. Accessed April 25, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03489044?"},{"key":"noi210060r36","unstructured":"Levetiracetam for Alzheimer's disease neuropsychiatric symptoms related to epilepsy trial (LAPSE). ClinicalTrials.gov identifier: NCT04004702. Accessed April 25, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04004702"},{"key":"noi210060r37","unstructured":"Study of AGB101 in mild cognitive impairment due to Alzheimer's disease (HOPE4MCI). ClinicalTrials.gov identifier: NCT03486938. Accessed April 25, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03486938"},{"key":"noi210060r38","unstructured":"Network-level mechanisms for preclinical Alzheimer's disease Development. ClinicalTrials.gov identifier: NCT03461861. Accessed April 25, 2021. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03461861"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2784539\/jamaneurology_vossel_2021_oi_210060_1636576251.67845.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T11:01:59Z","timestamp":1636628519000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2784539"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.3310","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,1]]}}}